Influence of Short-term Rosuvastatin Therapy on Endothelial Progenitor Cells and Endothelial Function

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Cardiovascular Pharmacology and Therapeutics

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1074248408331021PMID 19158317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial Injury and Repair: A Novel Theory for Atherosclerosis

  2008cited by this paper
• Circulating Endothelial Progenitor Cells as a New Marker of Endothelial Dysfunction or Repair in Acute Stroke

  2008cited by this paper
• Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk.

  2008cited by this paper
• Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia.

  2008cited by this paper
• Hypercholesterolemia suppresses Kir channels in porcine bone marrow progenitor cells in vivo.

  2007cited by this paper
• Influence of statin use on endothelial function: from bench to clinics.

  2007cited by this paper
• Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.

  2007cited by this paper
• Increased Ratio of CD31+/CD42− Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia

  2006influential reference
• The impact of progenitor cells in atherosclerosis

  2006cited by this paper
• Improvement of Endothelial Function by Systemic Transfusion of Vascular Progenitor Cells

  2006influential reference
• Nonpharmacological treatment of hypercholesterolemia increases circulating endothelial progenitor cell population in adults.

  2006cited by this paper
• The effects of HMG-CoA reductase inhibitor on vascular progenitor cells.

  2006cited by this paper
• Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.

  2005cited by this paper
• Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening.

  2004cited by this paper
• Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia.

  2004cited by this paper
• CD4+CD28− T Lymphocytes Contribute to Early Atherosclerotic Damage in Rheumatoid Arthritis Patients

  2004cited by this paper
• Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity

  2003cited by this paper
• Early vascular benefits of statin therapy

  2003cited by this paper
• Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

  2003influential reference
• Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 Transcription

  2003cited by this paper
• HMG-CoA Reductase Inhibitors Reduce Senescence and Increase Proliferation of Endothelial Progenitor Cells via Regulation of Cell Cycle Regulatory Genes

  2003cited by this paper
• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

  2003cited by this paper
• Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation: Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition

  2002cited by this paper
• Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia.

  2002cited by this paper
• HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.

  2001cited by this paper
• Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease

  2001cited by this paper
• Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women.

  2000cited by this paper

• Pleiotropic Effects of Statins: Focus on Endothelial Function, Plaque Stability and Thrombosis (Part II)

  2026cites this paper
• Development of a universal, oriented antibody immobilization method to functionalize vascular prostheses for enhanced endothelialization for potential clinical application

  2023cites this paper
• A tryptophan metabolite prevents depletion of circulating endothelial progenitor cells in systemic low-grade inflammation

  2023influential citation
• Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications

  2023cites this paper
• The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis

  2022cites this paper
• Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions.

  2022cites this paper
• The Role of Endothelial Progenitor Cells in Atherosclerosis and Impact of Anti-Lipemic Treatments on Endothelial Repair

  2022cites this paper
• Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk

  2022cites this paper
• Endothelial progenitor cells in the host defense response.

  2022cites this paper
• The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy

  2021cites this paper
• A comprehensive review on the lipid and pleiotropic effects of pitavastatin.

  2021cites this paper
• Effect of Beetroot Consumption on Serum Lipid Profile: A Systematic Review and Meta-Analysis.

  2021cites this paper
• Effects of structured home-based exercise training on circulating endothelial progenitor cells and endothelial function in patients with intermittent claudication

  2021cites this paper
• The number of circulating CD34-positive cells is an independent predictor of coronary artery calcification progression: Sub-analysis of a prospective multicenter study

  2021cites this paper
• Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia

  2021cites this paper
• Circulating progenitor cells and their interaction with platelets in patients with an acute coronary syndrome

  2019cites this paper
• Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study

  2019cites this paper
• Immune modulation by curcumin: The role of interleukin-10

  2019cites this paper
• Improvement of endothelial function by pitavastatin: a meta-analysis

  2018cites this paper
• Effect of intensive multifactorial treatment on vascular progenitor cells in hypertensive patients

  2018cites this paper
• A review on heme oxygenase-1 induction: is it a necessary evil

  2018cites this paper
• Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy

  2018cites this paper
• Stem/Progenitor Cells and Their Therapeutic Application in Cardiovascular Disease

  2018cites this paper
• The Yin and Yang of carbon nanomaterials in atherosclerosis.

  2018cites this paper
• Mécanismes impliqués dans la modulation de la néovascularisation post-ischémique : rôle de la rénine et des microARNs

  2018cites this paper
• The Role of Nutraceuticals in Statin Intolerant Patients.

  2018cites this paper
• The Role of Nutraceuticals in Statin Intolerant Patients

  2018cites this paper
• Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism

  2017cites this paper
• Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity

  2017cites this paper
• PCSK9 and diabetes: is there a link?

  2017cites this paper
• MRI Study on the Changes of Bone Marrow Microvascular Permeability and Fat Content after Total-Body X-Ray Irradiation

  2017cites this paper
• Neovascularization and Synaptic Function Regulation with Memantine and Rosuvastatin in a Rat Model of Chronic Cerebral Hypoperfusion

  2017cites this paper
• Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications

  2017cites this paper
• Lipid-lowering efficacy of rosuvastatin.

  2017cites this paper
• Curcumin and Endothelial Function: Evidence and Mechanisms of Protective Effects.

  2017cites this paper
• Effect of rosuvastatin or its combination with omega-3 fatty acids on circulating CD34(+) progenitor cells and on endothelial colony formation in patients with mixed dyslipidaemia.

  2016cites this paper
• Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial

  2016cites this paper
• Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease

  2015cites this paper
• The Role of Endothelial Progenitor Cell in Cardiovascular Disease Risk Factors.

  2015cites this paper
• Vascular injury and repair: a potential target for cell therapies.

  2015cites this paper
• Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells.

  2014cites this paper
• Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches.

  2014cites this paper
• Increasing Doses of Simvastatin Versus Combined Ezetimibe/Simvastatin

  2013cites this paper
• The Effect of Statins on Circulating Endothelial Progenitor Cells in Humans: A Systematic Review

  2013cites this paper
• Statins and stem cell modulation.

  2013cites this paper
• Rosuvastatin Changes Cytokine Expressions in Ischemic Territory and Preserves Heart Function After Acute Myocardial Infarction in Rats

  2013cites this paper
• Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study.

  2013cites this paper
• Mobilization of stem and progenitor cells in cardiovascular diseases

  2012cites this paper
• Proof Delivery Form

  2012cites this paper
• Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.

  2012cites this paper
• Statins Reduce Appropriate Implantable Cardioverter–Defibrillator Shocks in Ischemic Cardiomyopathy With no Benefit in Nonischemic Cardiomyopathy

  2012cites this paper
• Lipid lowering agents and the endothelium: an update after 4 years.

  2012cites this paper
• Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment

  2012cites this paper
• Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.

  2012cites this paper
• Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.

  2011cites this paper
• Targeting stem cell niches and trafficking for cardiovascular therapy.

  2011cites this paper
• Evidence of pre-procedural statin therapy a meta-analysis of randomized trials.

  2010cites this paper
• Statins and the Reduction of Sudden Cardiac Death

  2010cites this paper
• Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs

  2010cites this paper
• Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients

  2010cites this paper
• Statins and cardiac surgery.

  2010cites this paper
• Update on statin-mediated anti-inflammatory activities in atherosclerosis

  2009cites this paper
• Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study

  2009cites this paper